Biomarkers of tubular injury (e.g., plasma KIM-1) and inflammation (e.g., plasma TNFR1 and TNFR2) are associated with higher risks of CKD progression in patients with diabetic CKD and APOL-1–associated kidney diseases (26–29). The gene discussed is TNFRSF1A; the disease is kidney disorder.